Evidence map›Paper›PMID 35993492›Full record

ArticleEpidemiology and infection2022

Molecular epidemiology of paediatric invasive pneumococcal disease in Andalusia, Spain.

Beatriz de Felipe, Pablo Obando Pacheco, Begoña Carazo Gallego, David López Martín, Juan Luis Santos Pérez, Yolanda González Jiménez, María José Muñoz Vilches, Nerea Cardelo Autero, Verónica González Galán, Francisco José Morón and 5 more

Open access · goldAbstract read
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Beatriz de FelipeBiomedical Institute of Seville (IBiS), University of Seville, University Hospital Virgen del Rocío (HUVR)/CSIC, Seville, Spain.
Pablo Obando PachecoPediatric Unit, Hospital Universitario Virgen de Valme, Seville, Spain.
Begoña Carazo GallegoPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitario Regional de Málaga, Malaga, Spain.
David López MartínPediatric Unit, Hospital Costa del Sol, Marbella, Málaga, Spain.ORCID 0000-0002-6621-0938
Juan Luis Santos PérezPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Virgen de las Nieves, Granada, Spain.
Yolanda González JiménezPediatric Pneumology Unit, Hospital Universitario San Cecilio, Granada, Spain.
María José Muñoz VilchesPediatric Infectious Diseases and Immunodeficiencies Unit, HUVR, Seville, Spain.
Nerea Cardelo AuteroPediatric Unit, Hospital Costa del Sol, Marbella, Málaga, Spain.
Verónica González GalánMicrobiology Department, HUVR, IBiS, Seville, Spain.
Francisco José MorónBiomedical Institute of Seville (IBiS), University of Seville, University Hospital Virgen del Rocío (HUVR)/CSIC, Seville, Spain.
Juan Antonio Cordero VarelaBiomedical Institute of Seville (IBiS), University of Seville, University Hospital Virgen del Rocío (HUVR)/CSIC, Seville, Spain.
María José Torres SánchezBiomedical Institute of Seville (IBiS), University of Seville, University Hospital Virgen del Rocío (HUVR)/CSIC, Seville, Spain.
Antonio Medina ClarosPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitario Regional de Málaga, Malaga, Spain.
David Moreno PérezCoordinador del Plan Andaluz de Vacunas de Andalucía (PVA), Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitario Regional de Málaga, Malaga, Spain.
Ignacio ObandoBiomedical Institute of Seville (IBiS), University of Seville, University Hospital Virgen del Rocío (HUVR)/CSIC, Seville, Spain.ORCID 0000-0002-4516-1735
Instituto de Biomedicina de Sevilla · ESHospital Regional Universitario de Málaga · ESHospital Costa del Sol · ESHospital Universitario de Valme · ESHospital Universitario Virgen de las Nieves · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the impact of the introduction of pneumococcal conjugate vaccine 13 (PCV13) on the molecular epidemiology of invasive pneumococcal disease (IPD) in children from Andalusia. A population-based prospective surveillance study was conducted on IPD in children aged <14 years from Andalusia (2018-2020). Pneumococcal invasive isolates collected between 2006 and 2009 in the two largest tertiary hospitals in Andalusia were used as pre-PCV13 controls for comparison of serotype/genotype distribution. Overall IPD incidence rate was 3.55 cases per 100 000 in 2018; increased non-significantly to 4.20 cases per 100 000 in 2019 and declined in 2020 to 1.69 cases per 100 000 (incidence rate ratio 2020

Indexed as

Pneumococcal InfectionsChildHumansMolecular EpidemiologyPneumococcal VaccinesProspective StudiesSpainStreptococcus pneumoniaeVaccines, ConjugatePneumococcal VaccinesVaccines, ConjugateGenotypesinvasive pneumococcal diseasepneumococcal conjugate vaccineserotypesStreptococcus pneumoniae

Identifiers

PMID35993492
PMCPMC9727655
OpenAlexW4292596144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.